Literature DB >> 15048897

Plasma amyloid beta, apolipoprotein E, lacunar infarcts, and white matter lesions.

Ewoud J van Dijk1, Niels D Prins, Sarah E Vermeer, Albert Hofman, Cornelia M van Duijn, Peter J Koudstaal, Monique M B Breteler.   

Abstract

Lacunar brain infarcts and cerebral white matter lesions are frequently observed on magnetic resonance imaging scans in elderly subjects. These lesions are also frequent in patient with cerebral amyloid angiopathy. We examined whether plasma amyloid beta peptide (Abeta) levels are associated with lacunar infarcts and white matter lesions in the general population, and whether the apolipoprotein E (APOE) genotype modifies these associations. We studied 1,077 participants within the population-based Rotterdam Scan Study, who were 60 to 90 years of age and free of dementia. Cross-sectional associations were analyzed by regression models with adjustments for age, sex, creatinine levels, and hypertension. In APOE epsilon4 carriers, plasma Abeta levels were positively associated with lacunar infarcts and white matter lesions, whereas in noncarriers no associations were observed. Per standard deviation increase in Abeta(1-40) and Abeta(1-42) levels the odds ratios for lacunar infarcts were 1.72 (95% confidence interval [CI] = 1.22-2.43) and 1.93 (95% CI = 1.31-2.85), the periventricular white matter lesion grade increased by 0.32 (95% CI = 0.08-0.57) and 0.29 (95% CI = 0.00-0.57), and the subcortical white matter lesion volume increased by 0.48 ml (95% CI = 0.04-0.91) and 0.24 ml (95% CI = -0.27-0.75). Higher Abeta levels are associated with more lacunar infarcts and white matter lesions in elderly subjects who carry an APOE epsilon4 allele.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048897     DOI: 10.1002/ana.20050

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

Review 1.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

2.  Soluble amyloid-β levels and late-life depression.

Authors:  Ricardo S Osorio; Tyler Gumb; Nunzio Pomara
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI.

Authors:  Jon B Toledo; Hugo Vanderstichele; Michal Figurski; Paul S Aisen; Ronald C Petersen; Michael W Weiner; Clifford R Jack; William Jagust; Charles Decarli; Arthur W Toga; Estefanía Toledo; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2011-07-30       Impact factor: 17.088

4.  Elevation in plasma Abeta42 in geriatric depression: a pilot study.

Authors:  Nunzio Pomara; P Murali Doraiswamy; Lisa M Willoughby; Amy E Roth; Benoit H Mulsant; John J Sidtis; Pankaj D Mehta; Charles F Reynolds; Bruce G Pollock
Journal:  Neurochem Res       Date:  2006-04-01       Impact factor: 3.996

5.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

6.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

7.  Neuropathological basis of magnetic resonance images in aging and dementia.

Authors:  William J Jagust; Ling Zheng; Danielle J Harvey; Wendy J Mack; Harry V Vinters; Michael W Weiner; William G Ellis; Chris Zarow; Dan Mungas; Bruce R Reed; Joel H Kramer; Norbert Schuff; Charles DeCarli; Helena C Chui
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

8.  Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

Authors:  Adam M Brickman; Jordan Muraskin; Molly E Zimmerman
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

9.  Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Authors:  T T Seppälä; S-K Herukka; T Hänninen; S Tervo; M Hallikainen; H Soininen; T Pirttilä
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-05-16       Impact factor: 10.154

10.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.